Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marius M Hoeper

Showing results (81-90 of 311) with videos related to

Pageof 32
Sort By:
Respiratory Research|March 2, 2016
CXCL13 in idiopathic pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertensionKaren M Olsson, Sandra Olle, Jan Fuge, et al.
The Lancet. Respiratory Medicine|March 16, 2016
A global view of pulmonary hypertensionMarius M Hoeper, Marc Humbert, Rogerio Souza, et al.
Frontiers in Psychiatry|March 14, 2022
Health Disparities and Differences in Health-Care-Utilization in Patients With Pulmonary Arterial HypertensionDa-Hee Park, Tanja Meltendorf, Kai G Kahl, et al.
Circulation|December 10, 2003
Cardiovascular effects of systemic nitric oxide synthase inhibition with asymmetrical dimethylarginine in humansJan T Kielstein, Burcu Impraim, Solveig Simmel, et al.
Virchows Archiv : an International Journal of Pathology|April 26, 2008
Elastase-induced lung emphysema in rats is not reduced by hematopoietic growth factors when applied preventionallyAndreas Schmiedl, Tobias Lempa, Heinz G Hoymann, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|May 27, 2019
Intravenous treprostinil as an add-on therapy in patients with pulmonary arterial hypertensionKaren M Olsson, Manuel J Richter, Jan C Kamp, et al.
Clinical Science (London, England : 1979)|February 12, 2017
First identification of <i>Krüppel-like factor 2</i> mutation in heritable pulmonary arterial hypertensionChristina A Eichstaedt, Jie Song, Rebecca Rodríguez Viales, et al.
The Lancet. Respiratory Medicine|June 11, 2019
Macitentan for the treatment of portopulmonary hypertension (PORTICO): a multicentre, randomised, double-blind, placebo-controlled, phase 4 trialOlivier Sitbon, Jaume Bosch, Emmanuelle Cottreel, et al.
Pulmonary Circulation|June 8, 2026
Mental Disorders and Quality of Life in Patients With Pulmonary Arterial Hypertension Treated With SotaterceptJan Fuge, Karen M Olsson, Kira Remmert, et al.
Critical Care (London, England)|March 4, 2020
Effect of therapeutic plasma exchange on endothelial activation and coagulation-related parameters in septic shockKlaus Stahl, Julius J Schmidt, Benjamin Seeliger, et al.
Pageof 32

Showing results (81-90 of 311) with videos related to

Sort By:
Pageof 32
Respiratory Research|March 2, 2016
CXCL13 in idiopathic pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertensionKaren M Olsson, Sandra Olle, Jan Fuge, et al.
The Lancet. Respiratory Medicine|March 16, 2016
A global view of pulmonary hypertensionMarius M Hoeper, Marc Humbert, Rogerio Souza, et al.
Frontiers in Psychiatry|March 14, 2022
Health Disparities and Differences in Health-Care-Utilization in Patients With Pulmonary Arterial HypertensionDa-Hee Park, Tanja Meltendorf, Kai G Kahl, et al.
Circulation|December 10, 2003
Cardiovascular effects of systemic nitric oxide synthase inhibition with asymmetrical dimethylarginine in humansJan T Kielstein, Burcu Impraim, Solveig Simmel, et al.
Virchows Archiv : an International Journal of Pathology|April 26, 2008
Elastase-induced lung emphysema in rats is not reduced by hematopoietic growth factors when applied preventionallyAndreas Schmiedl, Tobias Lempa, Heinz G Hoymann, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|May 27, 2019
Intravenous treprostinil as an add-on therapy in patients with pulmonary arterial hypertensionKaren M Olsson, Manuel J Richter, Jan C Kamp, et al.
Clinical Science (London, England : 1979)|February 12, 2017
First identification of <i>Krüppel-like factor 2</i> mutation in heritable pulmonary arterial hypertensionChristina A Eichstaedt, Jie Song, Rebecca Rodríguez Viales, et al.
The Lancet. Respiratory Medicine|June 11, 2019
Macitentan for the treatment of portopulmonary hypertension (PORTICO): a multicentre, randomised, double-blind, placebo-controlled, phase 4 trialOlivier Sitbon, Jaume Bosch, Emmanuelle Cottreel, et al.
Pulmonary Circulation|June 8, 2026
Mental Disorders and Quality of Life in Patients With Pulmonary Arterial Hypertension Treated With SotaterceptJan Fuge, Karen M Olsson, Kira Remmert, et al.
Critical Care (London, England)|March 4, 2020
Effect of therapeutic plasma exchange on endothelial activation and coagulation-related parameters in septic shockKlaus Stahl, Julius J Schmidt, Benjamin Seeliger, et al.
Pageof 32